Pharmaceutical Company Raising Funds In Panchkula
Email
Phone
Google
LinkedIn
Facebook
About Business
The business is engaged in the pharmaceutical sector, offering a wide range of products through a third-party manufacturing model. All products are manufactured at WHO-GMP approved facilities, ensuring standard quality and regulatory compliance.
Product Portfolio
The company has built a portfolio of more than 80 products, with another 20–25 products currently in the pipeline. The range covers tablets, capsules, syrups, injectables, ointments, softgel capsules, ayurvedic products, and protein supplements.
Operations
Manufacturing is completely outsourced to approved third-party units. This setup allows the business to operate with lower overheads while maintaining flexibility in expanding its product range.
Licenses and Compliance
The business holds the required licenses, including import and export permissions, which support both domestic distribution and potential international expansion.
Financial Performance
The company is currently profitable, with net margin of approximately 25%. Operations started recently and have shown stable performance.
Ownership
The business has three partners, and one of them is looking to exit.
Opportunity
With an existing product base, compliant manufacturing partners, and steady sales, the business provides a ready platform for someone looking to enter or expand in the pharmaceutical space.
Clientele type
The primary markets include Jammu, Uttar Pradesh, Bihar, and Maharashtra, with wholesalers and distributors forming the main customer base.
Premises
LEASED
Lease per month (in INR): 45.00 K
Security Deposit (in INR): 45.00 K
Carpet Area: 1,000 sq ft
Asking Price Includes
The terms will be finalized through discussions with prospective investors.
Asking Price
INR 1.00 Cr
Minimum ticket size
INR 75.00 L
Reason
Funding is required to facilitate the exit of one partner and to support business expansion, including the launch of around 100 additional products.
Keywords
Business Tags
Fundraising for ₹10 Cr – 500 Cr
Confidential Process Completed in 120 Days
Strategic Preparation, Aligned Investor Outreach and Seamless Closure
Supported by Advisors with 26+ Years of Experience
